Table 1 Baseline characteristics of patients included in this study versus those lost to follow up.
Variables | Included (n = 288) | Lost to follow up (n = 93) | P Value |
|---|---|---|---|
Age (year), mean (SD) | 57.5 (13.2) | 57.0 (13.2) | 0.74 |
Male, n (%) | 192 (66.9) | 60 (64.5) | 0.67 |
BMI (kg/m2), mean (SD) | 24.6 (4.2) | 23.8 (2.8) | 0.19 |
Medical history, n (%) | |||
Hypertension | 188 (65.3) | 57 (61.3) | 0.49 |
Dyslipidemia | 10 (3.5) | 3 (3.2) | 1.00 |
Coronary heart disease | 23 (8.0) | 6 (6.5) | 0.63 |
Atrial fibrillation | 6 (2.1) | 1 (1.1) | 0.85 |
Stroke | 28 (10.6) | 4 (4.8) | 0.11 |
Pre-disability | 2 (0.7) | 4 (4.3) | 0.051 |
On admission status | |||
NIHSS score, median (IQR) | 6 (2–12) | 8 (4–11) | 0.20 |
GCS score, median (IQR) | 15 (13–15) | 15 (13–15) | 0.96 |
SBP (mmHg), mean (SD) | 156 (24) | 153 (22) | 0.46 |
DBP (mmHg), mean (SD) | 92 (15) | 91 (14) | 0.73 |
Hematoma location, n (%) | 0.18 | ||
Lobes | 41 (14.2) | 5 (5.4) | |
Basal ganglia region | 203 (70.5) | 72 (77.4) | |
Brain stem | 15 (5.2) | 8 (8.6) | |
Cerebellum | 17 (5.9) | 3 (3.2) | |
Intraventricular extension | 7 (2.4) | 3 (3.2) | |
TG on admission (mmol/L), median (IQR) | 1.4 (1.1–2.0) | 1.4 (1.0–1.9) | 0.24 |
HbA1c on admission (%),median (IQR) | 5.5 (5.0–6.0) | 5.4 (4.8–5.7) | 0.11 |
FPG on admission (mmol/L), median (IQR) | 5.4 (4.8–6.1) | 5.5 (4.7–6.3) | 0.77 |
FPG at 14d (mmol/L), median (IQR) | 4.9 (4.5–5.5) | 5.0 (4.5–5.5) | 0.07 |
2-h PG at 14d (mmol/L), median (IQR) | 7.7 (6.7–9.2) | 7.2 (6.3–8.8) | 0.05 |
